NEUROSENSE THERAPEUTICS LTD's ticker is and the CUSIP is M74240108. A total of 10 filers reported holding NEUROSENSE THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $38,000 | – | 15,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vanguard Personalized Indexing Management, LLC | 11,192 | $13,654 | 0.00% |
| UBS Group AG | 4,065 | $4,959 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 4 | $5 | 0.00% |
| CWM, LLC | 1,000 | $1 | 0.00% |
| Renaissance Technologies | 18,433 | $22 | 0.00% |